After being internalized by cancer cells, under the action of high GSH and esterase, the DAS and CP could be released in situ for inhibiting Src activity and inducing cell apoptosis, respectively, resulting in a synergistic anti-tumor effect [158]. Here, SRC is linked to neoplasm.